SARL PHARMACIE DE L'HERMITAGE : revenue, balance sheet and financial ratios

SARL PHARMACIE DE L'HERMITAGE is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in TAIN-L'HERMITAGE (26600), this company of category PME shows in 2018 a revenue of 3.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL PHARMACIE DE L'HERMITAGE (SIREN 500438700)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C 3 083 207 € 3 094 058 € 3 099 779 €
Net income 253 554 € 144 699 € 81 108 € 237 590 € 213 804 € 231 018 € 273 287 € 216 601 € 275 111 € 253 473 €
EBITDA N/C N/C N/C N/C N/C N/C N/C 333 766 € 423 283 € 401 850 €
Net margin N/C N/C N/C N/C N/C N/C N/C 7.0% 8.9% 8.2%

Revenue and income statement

In 2025, SARL PHARMACIE DE L'HERMITAGE generates positive net income of 254 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 253 k€ -> 254 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

253 554 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 30%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

30.214%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

65.833%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

60.9%

Solvency indicators evolution
SARL PHARMACIE DE L'HERMITAGE

Sector positioning

Debt ratio
30.21 2025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Good +12 pts over 3 years

In 2025, the debt ratio of SARL PHARMACIE DE L'HERMI... (30.21) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
65.83% 2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good -9 pts over 3 years

In 2025, the financial autonomy of SARL PHARMACIE DE L'HERMI... (65.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 140.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

140.757

Liquidity indicators evolution
SARL PHARMACIE DE L'HERMITAGE

Sector positioning

Liquidity ratio
140.76 2025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average -28 pts over 3 years

In 2025, the liquidity ratio of SARL PHARMACIE DE L'HERMI... (140.76) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SARL PHARMACIE DE L'HERMITAGE

Positioning of SARL PHARMACIE DE L'HERMITAGE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SARL PHARMACIE DE L'HERMITAGE is estimated at 4 027 735 € (range 2 733 240€ - 6 320 071€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2733k€ 4027k€ 6320k€
4 027 735 € Range: 2 733 240€ - 6 320 071€
NAF 5 année 2025

Valuation method used

Net Income Multiple
253 554 € × 15.9x = 4 027 735 €
Range: 2 733 240€ - 6 320 072€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SARL PHARMACIE DE L'HERMITAGE with other companies in the same sector:

Frequently asked questions about SARL PHARMACIE DE L'HERMITAGE

What is the revenue of SARL PHARMACIE DE L'HERMITAGE ?

The revenue of SARL PHARMACIE DE L'HERMITAGE in 2018 is 3.1 M€.

Is SARL PHARMACIE DE L'HERMITAGE profitable?

Yes, SARL PHARMACIE DE L'HERMITAGE generated a net profit of 254 k€ in 2025.

Where is the headquarters of SARL PHARMACIE DE L'HERMITAGE ?

The headquarters of SARL PHARMACIE DE L'HERMITAGE is located in TAIN-L'HERMITAGE (26600), in the department Drome.

Where to find the tax return of SARL PHARMACIE DE L'HERMITAGE ?

The tax return of SARL PHARMACIE DE L'HERMITAGE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL PHARMACIE DE L'HERMITAGE operate?

SARL PHARMACIE DE L'HERMITAGE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.